Department of Neurosurgery, School of Medicine, Kocaeli University, Kocaeli, Turkey; Pituitary Research Center, Kocaeli University, Kocaeli, Turkey.
Department of Endocrinology, School of Medicine, Kocaeli University, Kocaeli, Turkey.
World Neurosurg. 2019 Dec;132:e208-e216. doi: 10.1016/j.wneu.2019.08.196. Epub 2019 Sep 4.
The purpose of this study was to evaluate the preoperative clinical data and postoperative endocrinologic improvement, recurrence, and complications of Rathke's cleft cysts (RCCs) in a large series of endoscopic transsphenoidal surgery patients, operated in a single center.
Between 1997 and April 2018, 84 patients underwent endoscopic transsphenoidal surgery for RCCs. The presentation symptoms, endocrinologic results by localization and content of the cysts, surgical resections, postoperative complications, and recurrences were evaluated retrospectively.
Chronic headache was reported in 66.6% (56/84), visual field defects were present in 20.2% (17/84), and 23.8% (20/84) of the cases had pituitary dysfunction. Among the endocrinopathies, 17 of 17 patients had hyperprolactinemia, 2 of 7 patients had cortisol deficiency, and 2 of 13 had hypogonadism, which resolved after surgery. Preoperative pituitary hormone deficiency was associated with gelatinous tumor content (P = 0.044). However, there was no significant relationship between tumor localization and preoperative hormone insufficiency. Postoperative hypocortisolemia was seen more frequently in intrasellar RCCs (P = 0.048). Three new pituitary hormonal deficiencies were identified in postoperative patients (1 hypocortisolism, 1 diabetes insipidus, 1 hypogonadism). Gross total resection was achieved in 20 cases (23.8%), 9 of which were performed using an extended approach. Postoperative complications included 3 cerebrospinal fluid leakages and 1 epistaxis. Two patients presented with cyst recurrence at follow-up at 12 and 26 months.
Preoperative hormone deficiency was found to be associated with tumor content, independent of size or localization. The surgical aim for symptomatic RCCs should be decompression and this is effective for endocrinologic improvement. An extended endoscopic approach was adequate for total cyst wall removal in suprasellar cysts. Endoscopic transsphenoidal surgery was successful, with low complication rates, for decompression of intrasellar and suprasellar cysts in both complete cyst wall resection and cyst fenestration.
本研究旨在评估单中心大宗经蝶内镜手术患者的术前临床资料及术后内分泌改善、复发和并发症。
1997 年至 2018 年 4 月,84 例患者接受内镜经蝶窦手术治疗 Rathke 裂囊肿(RCC)。回顾性评估其临床表现、囊肿定位和内容物所致的内分泌结果、手术切除范围、术后并发症和复发情况。
84 例患者中,66.6%(56/84)表现为慢性头痛,20.2%(17/84)出现视野缺损,23.8%(20/84)存在垂体功能障碍。内分泌疾病中,17/17 例催乳素升高,2/7 例皮质醇缺乏,2/13 例性腺功能减退,术后均得到缓解。术前垂体激素缺乏与胶样肿瘤含量有关(P=0.044)。然而,肿瘤定位与术前激素不足之间无显著关系。RCC 位于鞍内者术后更易出现皮质醇减少(P=0.048)。术后新发 3 例垂体激素缺乏(1 例皮质醇缺乏、1 例尿崩症、1 例性腺功能减退)。20 例(23.8%)达到大体全切除,其中 9 例采用扩展入路。术后并发症包括 3 例脑脊液漏和 1 例鼻出血。2 例患者在随访中分别于 12 个月和 26 个月时出现囊肿复发。
术前激素缺乏与肿瘤含量有关,与大小或定位无关。有症状的 RCC 手术目的应是减压,这对内分泌改善有效。对于鞍上囊肿,扩展内镜入路足以彻底切除囊肿壁。内镜经蝶窦手术对于完全切除囊肿壁或囊壁开窗的鞍内和鞍上囊肿均能成功减压,并发症发生率低。